Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | |
|---|---|
| Revenue | $0 |
| Cost of revenue | $0 |
| Gross profit | $0 |
| Gross margin | — |
| R&D | $0 |
| Operating income | −$603.2K |
| EBITDA | −$484.1K |
| Net income | −$364.9K |
| Net margin | — |
| EPS (diluted) | -0.05 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds BCAC.
No tracked institution reports a position in BCAC as of their last filing.
No one on the platform has traded BCAC yet.
| +40.52% |
| $559M |
| — |
| HLXAHelix Acquisition Corp. | $13.25 | +19.80% | $516M | — |
| RONIRice Acquisition Corp. II | $13.12 | +11.66% | $566M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.